WO1997039123A3 - Secreted proteins - Google Patents

Secreted proteins Download PDF

Info

Publication number
WO1997039123A3
WO1997039123A3 PCT/US1997/006139 US9706139W WO9739123A3 WO 1997039123 A3 WO1997039123 A3 WO 1997039123A3 US 9706139 W US9706139 W US 9706139W WO 9739123 A3 WO9739123 A3 WO 9739123A3
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
proteins
secreted
disclosed
novel proteins
Prior art date
Application number
PCT/US1997/006139
Other languages
French (fr)
Other versions
WO1997039123A2 (en
Inventor
Kenneth Jacobs
John M Mccoy
Lisa A Racie
Edward R Lavallie
David Merberg
Vikki Spaulding
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst filed Critical Genetics Inst
Priority to EP97922304A priority Critical patent/EP0912731A2/en
Priority to JP53727097A priority patent/JP2001509004A/en
Priority to AU28016/97A priority patent/AU2801697A/en
Publication of WO1997039123A2 publication Critical patent/WO1997039123A2/en
Publication of WO1997039123A3 publication Critical patent/WO1997039123A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Novel proteins are disclosed.
PCT/US1997/006139 1996-04-18 1997-04-14 Secreted proteins WO1997039123A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP97922304A EP0912731A2 (en) 1996-04-18 1997-04-14 Secreted proteins
JP53727097A JP2001509004A (en) 1996-04-18 1997-04-14 Secreted protein
AU28016/97A AU2801697A (en) 1996-04-18 1997-04-14 Secreted proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63432596A 1996-04-18 1996-04-18
US08/634,325 1996-04-18

Publications (2)

Publication Number Publication Date
WO1997039123A2 WO1997039123A2 (en) 1997-10-23
WO1997039123A3 true WO1997039123A3 (en) 1998-02-26

Family

ID=24543331

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/006139 WO1997039123A2 (en) 1996-04-18 1997-04-14 Secreted proteins

Country Status (4)

Country Link
EP (1) EP0912731A2 (en)
JP (1) JP2001509004A (en)
AU (1) AU2801697A (en)
WO (1) WO1997039123A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280739B1 (en) * 1996-04-18 2001-08-28 Genetics Institute, Inc. Method of inhibiting angiogenesis using secreted proteins
WO1999000408A2 (en) * 1997-05-13 1999-01-07 Incyte Pharmaceuticals, Inc. Human transmembrane protein from the transmembrane 4 superfamily
US5872234A (en) 1997-06-27 1999-02-16 Incyte Pharmaceuticals, Inc. Human extracellular matrix proteins
WO1999055864A1 (en) * 1998-04-28 1999-11-04 Ono Pharmaceutical Co., Ltd. NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF
AU2390800A (en) * 1998-12-23 2000-07-12 Genetics Institute Inc. Secreted proteins
CA2409342A1 (en) * 2000-06-06 2001-12-13 Incyte Genomics, Inc. Extracellular messengers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996000738A1 (en) * 1994-06-30 1996-01-11 Warner-Lambert Company Endothelin antagonists ii

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996000738A1 (en) * 1994-06-30 1996-01-11 Warner-Lambert Company Endothelin antagonists ii

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EST Sequence HS096209 Acc. No. H62096; 8 October 1995 (1995-10-08), XP002042762 *
K JACOBS ET AL: "A novel method for isolating eukaryotic cDNA clones encoding secreted proteins", JOURNAL OF CELLULAR BIOCHEMISTRY - SUPPLEMENT, vol. 21A, 10 March 1995 (1995-03-10), pages 19, XP002027246 *
L. HILLIER ET AL.: "The WashU-Merck EST Project" *

Also Published As

Publication number Publication date
EP0912731A2 (en) 1999-05-06
AU2801697A (en) 1997-11-07
JP2001509004A (en) 2001-07-10
WO1997039123A2 (en) 1997-10-23

Similar Documents

Publication Publication Date Title
AU4214597A (en) Self-secreting proteases
AU4922497A (en) Interleukin-18-receptor proteins
AU3790497A (en) Anastomotic fitting
AU1251797A (en) Novel heteroaryl-oxazolidinones
AU6721696A (en) Cd44-like protein
AU5796298A (en) Secreted human proteins
EP0834959A3 (en) Connecting terminal
AU2850497A (en) Block former
AU3616797A (en) Phosphate starvation-inducible proteins
AU2181197A (en) Connecting part
WO1997039123A3 (en) Secreted proteins
AU8176798A (en) Secreted proteins
AU6000698A (en) Proteins
AU6275098A (en) Novel h-rev 107-like protein
WO1997039102A3 (en) Secreted proteins
WO1997039030A3 (en) Secreted proteins
AU4809497A (en) Secreted proteins
WO1998020130A3 (en) Secreted proteins and polynucleotides encoding them
AU2390800A (en) Secreted proteins
AU4326397A (en) Novel arylsulfotransferase
AU3873697A (en) Novel aryl-pyridazines
AU2997097A (en) Novel herbicidally-active concentrates
AU6522199A (en) Secreted protein zsig49
AU5137598A (en) Novel protein
AU1617495A (en) Novel protein PHBP-70

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1997 537270

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997922304

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997922304

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1997922304

Country of ref document: EP